Fortive Other Income (Expense) increased by 337.5% to $3.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 775.0%, from $400.00K to $3.50M. Over 3 years (FY 2021 to FY 2024), Other Income (Expense) shows a downward trend with a 61.0% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$4.60M | -$1.60M | -$4.60M | -$2.70M | -$3.10M | -$8.00M | -$1.80M | -$2.50M | -$7.80M | -$4.20M | -$2.90M | -$24.20M | -$8.80M | -$25.80M | $0.00 | $400.00K | $1.90M | $800.00K | $3.50M |
| QoQ Change | — | +65.2% | -187.5% | +41.3% | -14.8% | -158.1% | +77.5% | -38.9% | -212.0% | +46.2% | +31.0% | -734.5% | +63.6% | -193.2% | +100.0% | — | +375.0% | -57.9% | +337.5% |
| YoY Change | — | — | — | — | +32.6% | -400.0% | +60.9% | +7.4% | -151.6% | +47.5% | -61.1% | -868.0% | -12.8% | -514.3% | +100.0% | +101.7% | +121.6% | +103.1% | +775.0% |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Unallocated Corporate Costs and Other | $400.00K | $1.90M | $800.00K | — | $3.50M |
| Advanced Healthcare Solutions | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Intelligent Operating Solutions | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total | $400.00K | $1.90M | $800.00K | — | $3.50M |